ANTICANCER DRUG SENSITIVITY TESTS
\ˌantɪkˈansə dɹˈʌɡ sˌɛnsɪtˈɪvɪti tˈɛsts], \ˌantɪkˈansə dɹˈʌɡ sˌɛnsɪtˈɪvɪti tˈɛsts], \ˌa_n_t_ɪ_k_ˈa_n_s_ə d_ɹ_ˈʌ_ɡ s_ˌɛ_n_s_ɪ_t_ˈɪ_v_ɪ_t_i t_ˈɛ_s_t_s]\
Sort: Oldest first
-
Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals.
By DataStellar Co., Ltd
Word of the day
Proto Oncogene Proteins c erbB 2
- cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.
Nearby Words
- antical
- anticalculous
- anticancer
- anticancer drug combination
- anticancer drug combinations
- Anticancer Drug Sensitivity Tests
- anticancerous
- anticancrin
- anticancrosus
- anticanerin
- anticarcinogenic agents